View Item 

Show simple item record

Indolent zygomycosis associated with deferoxamine chelation therapy
dc.contributor.authorProkopowicz, G. P.en_US
dc.contributor.authorBradley, Suzanne F.en_US
dc.contributor.authorKaufffman, Carol A.en_US
dc.date.accessioned2010-06-01T18:44:26Z
dc.date.available2010-06-01T18:44:26Z
dc.date.issued1994-11en_US
dc.identifier.citationProkopowicz, G. P.; Bradley, Suzanne F.; Kaufffman, Carol A. (1994). "Indolent zygomycosis associated with deferoxamine chelation therapy." Mycoses 37(11-12): 427-431. <http://hdl.handle.net/2027.42/71938>en_US
dc.identifier.issn0933-7407en_US
dc.identifier.issn1439-0507en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/71938
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=7659131&dopt=citationen_US
dc.description.abstractThis paper describes a 71-year-old man with myelodysplasia who required multiple transfusions and subsequent deferoxamine chelation therapy and who then developed indolent cutaneous and probable pulmonary infection with Rhizopus species. The patient did not have rapidly progressive infection as has been described in almost all previously reported deferoxamine-treated patients with zygomycosis Amphotericin B therapy was successful in curing the infection. Zusammenfassung . Es wird der Fall eines 71-jÄhrigen Mannes mit Myelodysplasie beschrieben, der mehrfach Transfusionen mit anschließender Deferoxamin-Chelat-Therapie erhalten hatte und darauf einen schmerzlosen Hautprozeß und wahrscheinlich auch eine Lungeninfektion durch Rhizopus spec, entwickelte. Im Gegensatz zu den bisher bei fast allen Patienten mit Zygomykose nach Deferoxamin-Behandlung beschriebenen FÄllen entwickelte sich die Infektion im vorliegenden Fall langsam. Unter Amphotericin B-Therapie heilte die Infektion ab.en_US
dc.format.extent1122359 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights1994 Blackwell Publishingen_US
dc.subject.otherRhizopusen_US
dc.subject.otherZygomycosisen_US
dc.subject.otherDeferoxamineen_US
dc.subject.otherRhizopusen_US
dc.subject.otherZygomykoseen_US
dc.subject.otherDeferoxaminen_US
dc.titleIndolent zygomycosis associated with deferoxamine chelation therapyen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelDentistryen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDivisions of Infectious Diseases and Geriatric Medicine, Department of Internal Medicine, University of Michigan Medical School, Department of Veterans Affairs Medical Center, Ann Arbor, Michigan, USAen_US
dc.identifier.pmid7659131en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/71938/1/j.1439-0507.1994.tb00394.x.pdf
dc.identifier.doi10.1111/j.1439-0507.1994.tb00394.xen_US
dc.identifier.sourceMycosesen_US
dc.identifier.citedreferenceMarchevsky, A. M., Bottone, E. J., Geller, S. A. & Giger, D. K. ( 1980 ) The changing spectrum of disease, etiology, and diagnosis of mucormycosis. Human Pathol. 11, 457 – 464.en_US
dc.identifier.citedreferenceParfrey, N. A. ( 1986 ) Improved diagnosis and prognosis of mucormycosis. Medicine (Baltimore) 65, 113 – 123.en_US
dc.identifier.citedreferenceDaly, A. L., Velazquez, L. A., Bradley, S. F. & Kauffman, C. A. ( 1989 ) Mucormycosis: Association with deferoxamine therapy. Am. J. Med. 87, 468 – 471.en_US
dc.identifier.citedreferenceSands, J. M., Macher, A. M., Ley, T. J. & Nienhuis, A. W. ( 1985 ) Disseminated infection caused by Cunninghamella bertholletie in a patient with beta-thalassemia. Ann. Intern. Med. 102, 59 – 63.en_US
dc.identifier.citedreferenceBoelaert, J. R., Fenves, A. Z. & Coburn, J. W. ( 1991 ) Deferoxamine therapy and muycormycosis in dialysis patients: Report of an international registry. Am. J. Kidney Dis. 18, 660 – 667.en_US
dc.identifier.citedreferenceEiser, A. R., Slifkin, R. F. & Neff, M. S. ( 1987 ) Intestinal mucormycosis in hemodialysis patients following deferoxamine. Am. J. Kidney Dis. 10, 71 – 73.en_US
dc.identifier.citedreferenceBoelaert, J. R., van Roost, G. F., Vergauwe, P. L., Verbanck, J. J., de Vroey, C. & Segaert, M. F. ( 1988 ) The role of desferrioxamine in dialysis-associated mucormycosis: report of three cases and review of the literature. Clin. Nephrol. 29, 261 – 266.en_US
dc.identifier.citedreferenceSane, A., Manzi, S., Perfect, J., Herzberg, A. J. & Moore, J. O. ( 1989 ) Deferoxamine treatment as a risk factor for zygomycete infection. J. Infect. Dis. 159, 151 – 152.en_US
dc.identifier.citedreferenceIngram, C. W., Sennesh, J., Cooper, J. N. & Perfect, J. R. ( 1989 ) Disseminated zygomycosis: Report of four cases and review. Rev. Infect. Dis. 11, 741 – 754.en_US
dc.identifier.citedreferenceRex, J. H., Ginsberg, A. M., Fries, L. F., Pass, H. I. & Kwon-Chung, K. J. ( 1988 ) Cunningnamella bertholletiae infection associated with deferoxamine therapy. Rev. Infect. Dis. 10, 1187 – 1194.en_US
dc.identifier.citedreferenceWindus, D. W., Stokes, T. J., Julian, B. A. & Fenves, A. Z. ( 1987 ) Fatal Rhizopus infections in hemodialysis patients receiving deferoxamine. Ann. Intern. Med. 107, 678 – 680.en_US
dc.identifier.citedreferenceBrennan, R. O., Crain, B. J., Proctor, A. M. & Durack, D. T. ( 1983 ) Cunninghamella: A newly recognized cause of rhinocerebral mucormycosis. Am. J. Clin. Pathol. 80, 98 – 102.en_US
dc.identifier.citedreferenceSugar, A. M. ( 1992 ) Mucormycosis. Clin. Infect. Dis. 14 ( Suppl. 1 ), S126 – S129.en_US
dc.identifier.citedreferenceMeyer, R. D., Rosen, P. & Armstrong, D. ( 1972 ) Phycomycosis complicating leukemia and lymphoma. Ann. Intern. Med. 77, 871 – 879.en_US
dc.identifier.citedreferenceLyon, D. T., Schubert, T. T., Mantia, A. G. & Kaplan, M. H. ( 1979 ) Phycomycosis of the gastrointestinal tract. Am. J. Gastroenterol. 72, 379 – 394.en_US
dc.identifier.citedreferenceStave, G. M., Heimberger, T. & Kerkering, T. M. ( 1989 ) Zygomycosis of the basal ganglia in intravenous drug users. Am. J. Med. 86, 115 – 117.en_US
dc.identifier.citedreferenceMeyer, R. D., Kaplan, M. H., Ong, M. & Armstrong, D. ( 1973 ) Cutaneous lesions in disseminated mucormycosis. JAMA 225, 737 – 738.en_US
dc.identifier.citedreferenceVainrub, B., Macareno, A., Mandel, S. & Musher, D. M. ( 198 ) Wound zygomycosis (mucormycosis) in otherwise healthy adults. Am. J. Med. 84, 546 – 548.en_US
dc.identifier.citedreferencePaparello, S. F., Parry, R. L., MacGillivray, D. C., Brock, N. & Mayers, D. L. ( 1992 ) Hospital-acquired wound mucormycosis. Clin. Infect. Dis. 14, 350 – 352.en_US
dc.identifier.citedreferenceGartenberg, G., Bottone, E. J., Keusch, G. T. & Weitzman, I. ( 1978 ) Hospital-acquired mucormycosis ( Rhizopus rhizopodiformis ) of skin and subcutaneous tissue. Epidemiology, mycology, and treatment. N. Engl. J. Med. 299, 1115 – 1118.en_US
dc.identifier.citedreferenceGeller, J. D., Peters, M. S. & Su, W. P. D. ( 1993 ) Cutaneous mucormycosis resembling superficial granulomatous pyoderma in an immunocompetent host. J. Am. Acad. Deermatol. 29, 462 – 465.en_US
dc.identifier.citedreferenceBoelaert, J. R., de Locht, M. & Schneider, Y-J. ( 1994 ) The effect of deferoxamine on different zygomycetes. J. Infect. Dis. 169, 231 – 232.en_US
dc.identifier.citedreferenceHolzberg, M. & Artis, W. M. ( 1983 ) Hydroxamate siderophore production by opportunistic and systemic fungal pathogens. Infect. Immun. 40, 1134 – 1139.en_US
dc.identifier.citedreferenceWeinberg, E. D. ( 1978 ) Iron and infections. Microbiol. Rev. 42, 45 – 66.en_US
dc.identifier.citedreferencevan Cutsem, J. & Boelaert, J. R. ( 1989 ) Effects of deferoxamine, feroxamine, and iron on experimental mucormycosis (zygomycosis). Kidney Int. 36, 1061 – 1068.en_US
dc.identifier.citedreferenceVerdonck, A. K., Boelaert, J. R., Gordts, B. Z. & Van Landuyt, H. W. ( 1993 ) Effect of ferrioxamine on the growth of Rhizopus. Mycoses 36, 9 – 12.en_US
dc.identifier.citedreferenceBoelaert, J. R., de Locht, M., van Cutsem, J. et al. ( 1993 ) Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies. J. Clin. Invest. 91, 1979 – 1986.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1439-0507.1994.tb00394.x.pdf
Size:
1.070MB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.